A study suggests that high expression of LSAPM in ovarian cancer can serve as a specific target for ovarian cancer immunotherapy (24).Our study has found that LSAMP is highly expressed in extrahepatic cholangiocarcinoma tissues and it is highly correlated with patient prognosis. This evidence concerns the gene LSAMP and ovarian cancer.